MOSHKEVICH SOLOMON (PRESIDENT, CLINICALDIAGNOSTICS) sold 2.7% of their position (3K shares) of NATERA, INC. on the open market
Open‑market sale worth $1.24M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 10/3/2026ACC: 0002010019-26-000030
Officer· PRESIDENT, CLINICALDIAGNOSTICS
Since Feb 2026
-3K
Net shares
Net seller
$1.24M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
3K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−200.00
Price / share
$411.62
Trade value
$82.32K
% of position
0.2%
10/1/2026
109.91K→109.71K
Common Stock
Direct
Shares
−954.00
Price / share
$413.11
Trade value
$394.10K
% of position
0.9%
10/1/2026
109.71K→108.76K
Common Stock
Direct
Shares
−1.85K
Price / share
$415.07
Trade value
$766.22K
% of position
1.7%
10/1/2026
108.76K→106.91K
Total
Net shares
−3K
Net value
-$1.24M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/1/2026 | S · Sale | −200.00 | $411.62 | $82.32K | 0.2% | 109.91K | 109.71K |
| Common Stock Direct | 10/1/2026 | S · Sale | −954.00 | $413.11 | $394.10K | 0.9% | 109.71K | 108.76K |
| Common Stock Direct | 10/1/2026 | S · Sale | −1.85K | $415.07 | $766.22K | 1.7% | 108.76K | 106.91K |
| Total | −3K | -$1.24M | ||||||
Derivative Transactions0
No derivative transactions reported